Matthew Pellecchia

Matthew Pellecchia currently serves as a Health Science Advisor at Otsuka Pharmaceutical Co., Ltd., a position held since February 2023. Prior to this role, Matthew worked as a Territory Sales Manager at Aquestive Therapeutics, focusing on sales within the neurology rare disease sector while covering New Jersey, eastern Pennsylvania, and northern Delaware from May 2021 to November 2022. Matthew's extensive experience in the pharmaceutical industry includes a decade at Sunovion Pharmaceuticals as both a Regional Field Based Trainer and a Senior Institutional Account Specialist, and roles at Eli Lilly and Company as a Senior Hospital Sales Representative and Senior Office Based Representative, where involvement included the successful launch of products such as Strattera, Cymbalta, and Symbyax. Matthew holds a Master of Business Administration with a focus on Pharmaceutical Marketing and Management from Saint Joseph's University, as well as a Bachelor's degree in Business Administration and Management from Seton Hall University.